Q&A
-
Q&A
Inside Senseonics’ commercial overhaul and what’s next
The diabetes tech firm recently brought its sales and marketing teams in-house after taking over commercialization of its device from Ascensia Diabetes Care.
By Elise Reuter • Aug. 13, 2026 -
Q&A
When does it make sense to build software instead of buy? One health system’s answer.
NYU Langone Health and Dana-Farber Cancer Institute built an oncology decision support tool to guide clinicians through treatment. Now, the institutions are commercializing the product so other health systems can use it too.
By Jill Hughes • Aug. 10, 2026 -
Q&A
Medtronic on the future of AI-assisted surgery
Medtronic’s George Murgatroyd says an advanced computing platform that works with the company’s Hugo robot will power AI algorithms that can assist surgeons as they operate.
By Susan Kelly • Aug. 5, 2026 -
Q&A
What J&J’s Ottava robot brings to the surgical table
Rocco De Bernardis, global president for Ottava, gets into the details of what makes the new robotic surgery system different from the competition and how the healthcare giant plans to roll it out.
By Susan Kelly • July 30, 2026 -
Q&A
Why Aidoc is taking a generative AI device to the FDA
Aidoc is bringing a system that can interpret images and make draft reports for radiologists to the FDA as the medtech industry awaits clarity on regulation of generative AI. Ensuring safety is paramount, said CEO Elad Walach.
By Elise Reuter • July 27, 2026 -
Q&A
Abbott’s cancer diagnostics vision: ‘There’s always a hunger to make these tests better’
Jorge Garces, who joined Abbott to oversee scientific strategy for cancer diagnostics after it acquired Exact Sciences, discusses the future of the field.
By Susan Kelly • July 15, 2026 -
Q&A
BD’s Bilal Muhsin talks AI in connected care
Muhsin discussed how BD is rolling out a new medication dispenser and a software platform that pulls together data from the company’s various devices.
By Elise Reuter • Updated June 25, 2026 -
Q&A
Olympus’ Keith Boettiger on robotic GI surgery push
Keith Boettiger, head of Olympus’ gastrointestinal solutions division, delves into the endoscopy leader’s endoluminal robotics strategy.
By Susan Kelly • June 5, 2026 -
Q&A
Natera’s Solomon Moshkevich on how MRD testing pinpoints cancer recurrence
Molecular residual disease testing could one day be as ubiquitous as a CT scan, says Natera’s president of clinical diagnostics.
By Susan Kelly • May 29, 2026 -
Q&A
Ōura’s Ricky Bloomfield proposes new regulatory pathway for wearable health features
The chief medical officer is interested in an easier path to market for health screening features in wearable devices.
By Elise Reuter • Jan. 5, 2026 -
Q&A
Shockwave’s Nick West on shaking up treatment for blocked arteries
The chief medical officer for the new J&J unit discussed intravascular lithotripsy’s rapid growth and what to expect from the pipeline in a conversation with MedTech Dive.
By Susan Kelly • Nov. 21, 2025 -
Q&A
Resmed CEO Mick Farrell on new technologies, tariffs and AI
The incoming AdvaMed chair talked about updates to Resmed’s products and how the company is handling competitive dynamics and tariffs.
By Elise Reuter • Updated Nov. 18, 2025 -
Q&A
Biolinq’s Jared Tangney on making CGMs unintimidating
The chief technology officer and co-founder explained the technology and design choices that went into Biolinq’s device, which he hopes will be easier to use than other glucose monitors.
By Elise Reuter • Oct. 20, 2025 -
Q&A
Que Dallara on Medtronic’s diabetes spinoff, pipeline and Abbott partnership
Dallara, president of Medtronic’s diabetes business, discussed the segment’s turnaround and why she sees a benefit in becoming a standalone firm.
By Elise Reuter • Sept. 25, 2025 -
Q&A
Abbott’s new diabetes leader on latest sensors, partnerships and Type 2 coverage
Ahead of the American Diabetes Association’s Scientific Sessions, Chris Scoggins said Abbott’s ambition is to be the most broadly connected diabetes tech company.
By Elise Reuter • June 12, 2025 -
Q&A
ADA’s Osagie Ebekozien on diabetes tech for Type 2, new CGM standards
Ebekozien, chief quality officer of the American Diabetes Association, said the nonprofit is seeing a shift with more devices authorized for Type 2 diabetes.
By Elise Reuter • May 9, 2025 -
Q&A
Dexcom COO on 15-day glucose sensor, Type 2 coverage
Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors and an FDA warning letter.
By Elise Reuter • March 25, 2025 -
Q&A
Why HCA is ‘all in’ on surgical robotics
Thomas Payne, HCA Healthcare’s national medical director of robotics, explains how the largest U.S. health system is vetting a new crop of market entrants.
By Susan Kelly • March 24, 2025 -
Q&A
Steven Mickelsen, Farapulse founder, eyes next frontier in pulsed field ablation
Mickelsen, whose work led to the development of Boston Scientific’s fast-growing Farapulse device, is building a new PFA tool for ventricular tachycardia as CEO of startup Field Medical.
By Susan Kelly • March 4, 2025 -
Q&A
Why health systems should be ‘clear-eyed’ about business goals for AI tools
Caroline Pearson, the executive director of the Peterson Health Technology Institute, discusses the institute’s new task force studying the financial, efficiency and workforce effects of AI products.
By Emily Olsen • Feb. 10, 2025 -
Q&A
Few medical devices are designed for children. An FDA-Children’s National collaboration aims to change that.
Kolaleh Eskandanian, chief innovation officer at Children’s National Hospital, said the partnership is meant to address the many challenges with developing devices for children and infants.
By Elise Reuter • Jan. 2, 2025 -
Robots, AI and PFA: The top medtech Q&As of 2024
From challenging market leaders to the growing influence of artificial intelligence, medical device executives had a lot to discuss this year. Check out MedTech Dive’s top Q&As of 2024.
By Ricky Zipp • Dec. 20, 2024 -
Q&A
How CMR Surgical is taking on robotics’ ‘800-pound gorilla’
“I don't think a monopoly market is healthy,” said CMR co-founder Mark Slack, discussing robotic surgery pioneer Intuitive Surgical’s continuing dominance in the market.
By Susan Kelly • Dec. 3, 2024 -
Verily alum looks to improve access to retinal scans
CEO Vicky Demas joined Identifeye Health, a startup building an AI-supported retinal imaging device, after stints with Google’s sibling Verily and Grail.
By Elise Reuter • Nov. 21, 2024 -
Q&A
Insulet’s Trang Ly on overcoming ‘clinical inertia’ in diabetes care
Automated insulin delivery for Type 2 patients can help change minds among physicians who have been reluctant to prescribe pump therapy, the chief medical officer said in an interview.
By Susan Kelly • Aug. 27, 2024